University of Cambridge

Dreamer, Rebel or Zigzagger? Research reveals nine types of procrastinators and how to help them all

Working out which types of procrastinators we are is crucial to overcoming a problem that harms our finances, health and ...

ADHD medication misuse declines among US adults, study finds

Misuse of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) has declined sharply. In 2023, ...

A Teenager Just Turned Eye Scans Into an AI Test for Autism and ADHD

From school project to breakthrough: how a teenager built an AI tool that reads the eye to detect autism and ADHD.

ADHD brains are prone to wandering. That’s a secret weapon in the workplace

New research suggests that certain ADHD traits could unlock greater creative thinking. Some of the symptoms that create ...

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHDNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) ...

Tyneside mum says ADHD is a 'strength' helping to power her award-winning small business

Jen Fowler said she had learned to see how living with ADHD had helped her, rather than holding her back.
The Tech Edvocate

Conflict Resolution Strategies for Students with ADHD

Spread the love“`html Conflict is a natural part of any social interaction, but for students with ADHD, navigating these ...

Psychology says people with ADHD have a far greater aptitude for creative thinking and intuitive reasoning than neurotypical people

ADHD has had a strange run. For a long time, it was barely taken seriously — a thing restless boys supposedly grew out of, ...

How Jessica McCabe turned 'How to ADHD' into a trusted online resource

From organizing her own thoughts to working with researchers, the creator shares how her channel has evolved over the past ...

First patient dosed in Axsome’s FOCUS-3 trial of solriamfetol for ADHD

Axsome Therapeutics has dosed the first patient in its FOCUS-3 Phase III clinical trial assessing solriamfetol in adolescents ...

Jessica McCabe built 'How to ADHD' by solving her own biggest problem

Jessica McCabe started posting on YouTube because she knew she couldn't lose it. McCabe lost notebooks and phones and was ...

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

FOCUS-3 (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of ...